NCT05372484 Rice Technologies for Cervical Cancer Screening and Diagnosis
| NCT ID | NCT05372484 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Cervical Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 678 participants |
| Start Date | 2021-03-24 |
| Primary Completion | 2028-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 678 participants in total. It began in 2021-03-24 with a primary completion date of 2028-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to compare the accuracy of the lateral flow test to detect HPV at the POC with commercially available HPV test and to determine the diagnostic accuracy and reliability of a multimodal optical imaging system to detect cervical dysplasia, with the gold reference standard of histopathology.
Eligibility Criteria
Inclusion Criteria: 1. 25 - 49 year old women 2. Women with a positive cervical cancer screening test (abnormal cytology, positive VIA and/or positive HPV test) 3. Women with intact cervix 4. Women who are not pregnant and with a negative pregnancy test (within 14 days from the date of enrollment) ) and not currently breastfeeding 5. Willing and capable of providing informed consent Exclusion Criteria: 1. Women under 25 or over 49 years old 2. Women who have undergone a total hysterectomy (with removal of the cervix) 3. Women who are pregnant or breastfeeding
Contact & Investigator
Kathleen Schmeler, MD
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT05372484 clinical trial?
This trial is open to female participants only, aged 25 Years or older, up to 49 Years, studying Cervical Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05372484 currently recruiting?
Yes, NCT05372484 is actively recruiting participants. Contact the research team at mpsalcedo@mdanderson.org for enrollment information.
Where is the NCT05372484 trial being conducted?
This trial is being conducted at Houston, United States, Maputo, Mozambique, Maputo, Mozambique, Maputo, Mozambique.
Who is sponsoring the NCT05372484 clinical trial?
NCT05372484 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Kathleen Schmeler, MD at M.D. Anderson Cancer Center. The trial plans to enroll 678 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.